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Lymphadenectomy (RAIL)
Victor Enrique Corona-Montes, Eduardo Gonzalez-Cuenca 
and Marcos Tobias-Machado
Abstract
The objective of the following chapter is to describe thoroughly the surgical 
technique for a robotic-assisted inguinal lymphadenectomy for penile cancer, and 
the surgery has been through modifications from its creation to “the Robotic Era.” 
Penile cancer is a rare neoplasm, with an estimated 1570 cases in the United States. 
The spread is predictable to the inguinal lymph nodes, where 1–2% of patients will 
present distant metastases. The first draining lymph area is found in the inguinal 
region and the secondary spread in the pelvic region, main reason for the inguinal 
part of the treatment of penile cancer under different indications. Radical resection 
of inguinal metastases of penile cancer is the standard treatment for this technique, 
which has been adapted to become a minimally invasive surgery compared to an 
open inguinal lymphadenectomy, which entails a high incidence of morbidity that 
stands at 50–90%. A robotic-assisted inguinal lymphadenectomy, despite its high 
cost, is a feasible technique when carried out in specialized centers that can reduce 
morbidity rates and offer good oncological results, less blood loss, and shorter 
hospital stay.
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1. Introduction
In 2002, Ian M. Thompson and Jay T. Bishop conceived the idea of an endoscopic 
and subcutaneous approach for inguinal lymph node dissection applying laparo-
scopic techniques. The endoscopic subcutaneous approach for a modified inguinal 
lymphadenectomy (ESMIL) procedure was described in a cadaveric model and 
performed in 2003 on a patient with T3N1M0 squamous cell carcinoma of the penis 
with an adequate identification of anatomical landmarks and overall feasibility 
[1]. In 2007, Tobias-Machado et al. reported reduced complications (20% vs 70%), 
shorter hospitalization times, more favorable cosmetic outcomes, and optimal 
oncologic outcomes regarding a refined technique coined as “video-endoscopic 
inguinal lymphadenectomy” (VEIL), in contrast with more traditional open 
procedures [2, 3].
International literature proclaimed the benefits and fewer complications that 
minimally invasive lymph node resection implied, such as skin necrosis without 
compromising oncologic control. These facts paved the way for new technological 
advances to be employed, as in the case for the “robotic-assisted inguinal lymphade-
nectomy” (RAIL). This robotic technology allows for a three-dimensional operative 
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field, tremor filter, and articulated instruments, which grant the surgeon improved 
visibility, identification of anatomical landmarks, dexterity, and improved ergo-
nomics, thus overcoming the limitations of VEIL. Josephson and associates were 
the first to describe the feasibility of a nonsimultaneous bilateral RAIL using the da 
Vinci S robotic system [4].
In 2013, Matin et al. published a prospective study where the oncologic efficacy 
of RAIL to adequately stage the disease was confirmed, with an independent surgeon 
assessment by a direct visual evaluation of the dissection field through a small inguinal 
incision [5]. Russell also described a lower complication rate of the RAIL approach in 
comparison with VEIL technique (10% vs. 40%), although the group of VEIL patients 
was smaller [6]. Sotelo et al. and Ahlawat et al. have described different techniques 
that allows for a simultaneous bilateral RAIL to be performed without moving the 
robotic system across the operating room and maintaining an adequate reproducibility 
as well as allowing a bilateral staging procedure in the same surgical time [7, 8].
The author of the chapter described the first RAIL carried out in Mexico in the 
year 2015. It was performed on a 73-year-old patient with squamous cell carcinoma 
of the penis (T3N0M0G1), and he underwent a radical penectomy 4 weeks earlier 
the lymphadenectomy. The bilateral RAIL using the da Vinci Si HD surgical system 
was performed, and both saphenous veins were successfully preserved [9].
New technological advances, refinements, and modifications in the minimally 
invasive lymph node dissection technique will continue to reduce the morbidity and 
complications and improve the quality of life of the penile cancer patient.
2. Epidemiology of penile cancer
Penile cancer is a rare neoplasm, making up for less than an estimated 1% of all 
types of cancer in the United States, translating to an approximate amount of 2100 
new cases and 400 deaths annually [9]. According to the Global Cancer Observatory, 
the estimated number of incident cases is 34,475 and a mortality of 15,138 cases 
in all ages [10]. This type of cancer is more common in less developed areas of the 
world (i.e., Africa, Asia, and South America), where it accounts up to 10–20% of all 
malignancies in men. Penile cancer is considered a disease that typically affects older 
men, where males between ages 55 and 58 are more prone to be affected.
This tumor is unusual in younger patients (<40 years old), although cases have 
been reported [11]. The ethnicity has been demonstrated to have no impact in the 
incidence, but it does play a role as a risk factor regarding survival outcomes (it is 
worse for African-American ethnicities).
Multiple factors are associated with a risk of developing penile cancer, such as 
suffering from genital warts (OR 7.6), penile tears (OR 5.2), chronic penile rash  
(OR 3.2), penile injuries (OR 3.5), phimosis (seven times higher risk), human papil-
loma virus (DNA identified >30%), human immunodeficiency virus (4–8 times 
higher risk), tobacco exposure (3 times more likely), and lichen sclerosis (balanitis 
xerotica obliterans) [12].
The spread is predictable to the inguinal lymph nodes, where only 1–2% of patients 
will present distant metastases. Approximately 20% of patients with clinically nonpal-
pable inguinal nodes harbor occult metastases. The first draining lymph node group 
is found both in the superficial and in the deep inguinal region (superomedial zone), 
whereas the second lymph node group spread lies in the ipsilateral pelvic region and, 
lastly, in the retroperitoneum (para-caval/para-aortic lymph nodes) [13].
Penile cancer patients in the low-risk group (Tis, Ta, T1G1, No LVI) have a <16% 
metastatic rate to the lymph nodes, intermediate risk (T1G2) have 17–50%, and high 
risk (T1G3, >T2, LVI) have 68–73% metastatic rate [14].
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Radical resection of inguinal metastases of penile cancer is the standard treat-
ment, and the greatest single predictor of survival in squamous cell carcinoma 
of the penis is the incidence and extent of lymph node involvement [11, 14]. The 
objective of the lymph node resection is providing accurate pathology staging and 
if disease exists in the nodes alter its natural history and pattern of metastasis. 
Men found to have a single node involved (N1) had a 100% 3-year disease-specific 
survival. The presence of 1–3 involved nodes predicts a 5-year overall survival rate 
of 75.6%, whereas for 4 or 5 nodes involved the rate is at 8.4 and 0% for patients 
with more than 5 positive nodes [14].
This technique has been adapted as a minimally invasive surgery, and in com-
parison with the open inguinal lymphadenectomy, it preferred because of the 
latter’s high incidence of morbidity that stands a 50–90% rate regarding an open 
approach [2]. Robotic-assisted inguinal lymphadenectomy, aside from its high cost, 
is a feasible technique when carried out in specialized centers reduces morbidity 
and provides adequate oncological results, less blood loss, and shorter hospital stay.
3. Anatomical aspects
The femoral vessels are found in the femoral triangle and formed laterally by 
the sartorius muscle laterally, superiorly by the inguinal ligament superiorly, and 
medially by the long adductor medially. The junction between the saphenous 
and femoral vessels is located approximately two fingerbreadths lateral and two 
fingerbreadths inferior to the pubic tubercle. The saphenous vein passes anteriorly 
through the fossa ovalis and elapses with the superficial inguinal region. The struc-
tures that will be found in the femoral triangle are (from lateral to medial) femoral 
nerve, the femoral artery, the femoral vein, and the deep inguinal lymph nodes. 
These last three are located inside the femoral sheath [13] Figure 1.
The fascia lata separates the inguinal lymph nodes into superficial and deep 
groups. The superficial inguinal lymph nodes are situated in the deep membranous 
layer of the superficial fascia of the thigh (Camper’s fascia), approximately com-
posed by 4 or up to 25 nodes. The superficial inguinal nodes have been divided into 
5 anatomic groups by Daseler in 1948 [13, 15] (Figure 2).
1. Superomedial nodes (I) around the superficial external pudendal and superfi-
cial epigastric veins.
2. Superolateral nodes (II) around the superficial circumflex vein.
3. Inferolateral nodes (III) around the lateral femoral cutaneous and superficial 
circumflex veins.
4. Inferomedial nodes (IV) around the greater saphenous vein.
5. Central nodes (V) around the saphenofemoral junction.
The superficial external pudendal vein, superficial circumflex vein, and the lat-
eral femoral cutaneous vein are branches of the greater saphenous vein (Figure 3).
The deep inguinal nodes are located deep into the fascia lata and lie medial to 
the femoral vein in the femoral triangle. The node of Cloquet is the most cephalad 
node in the deep inguinal region, located between the femoral vein and the lacunar 
ligament.
The standard or full template for the inguinal lymph node dissection 
includes Daseler’s 5 group nodes in the superficial dissection and the deep 
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inguinal nodes from the femoral triangle, limiting the dissection lateral to the 
femoral artery, which eliminates the risk of injury to the femoral nerve. This 
template includes the ligation of the saphenous vein as it emerges from the 
femoral vein. The template requires the superficial dissection of the first group 
lymph nodes entirely, as well as a portion of the second and fifth group lymph 
nodes, the inferior group nodes are not dissected, the deep dissection remains 
the same. The modified template was described to reduce the complication rate, 
which can be also accomplished by the minimally invasive approach.
Figure 1. 
Femoral triangle (left limb).
Figure 2. 
Schematics of Daseler zones (left limb).
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4. Surgical indications for RAIL
The treatment of regional lymph nodes is decisive for patient survival. A cure for 
the disease confined to regional nodes can be achieved and a radical lymphadenec-
tomy is the treatment of choice. For this section, a description of the actual surgical 
indications for inguinal lymphadenectomy in the different group risks and clinical 
stages will be presented [16, 17].
4.1 Patients with clinically normal inguinal lymph nodes (cN0)
Micrometastatic disease occurs in up to 25% of the patients and invasive lymph 
node staging is necessary. The indication for an inguinal lymphadenectomy is for 
intermediate (T1b, Grade 1 or 2) and high-risk tumors (T1b, Grade 3 or 4; any T2 
or greater), which are considered to have an elevated risk of lymphatic spread. 
The superficial inguinal lymphadenectomy is an option that can be completed 
(radical) if one pathological lymph node is found without extranodal extension. If 
extranodal extension is present or ≥2 lymph nodes are positive, inguinal and pelvic 
lymphadenectomy should be considered.
4.2 Patients with palpable uni- or bilateral inguinal nodes (cN1/cN2)
Metastatic disease is very likely and lymph node surgery (radical inguinal 
lymphadenectomy) with histopathology is necessary. Treatment in these patients 
should not be delayed given that the metastatic spread continues. If a high-risk 
primary lesion was identified, a complete inguinal lymphadenectomy + contralat-
eral superficial lymphadenectomy should be performed. If ≥2 inguinal nodes are 
positive or ≥1 inguinal node is positive with extranodal extension, an ipsilateral 
pelvic lymph node dissection is recommended to be performed.
4.3 Patients with bulky inguinal nodes
In this scenario, the patients will require multimodal treatment consisting 
of chemotherapy and surgery. The radical inguinal lymphadenectomy will be 
indicated after a positive metastatic (fine needle aspiration) disease in unilateral 
Figure 3. 
Saphenous vein configuration.
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mobile ≥4 cm lymph node. If ≥2 nodes are positive or have extranodal extension, a 
pelvic lymphadenectomy should be performed and adjuvant chemotherapy consid-
ered. In the scenario where the lymph node is ≥4 cm and fixed or mobile bilateral, 
neoadjuvant chemotherapy should be administrated after the positive finding in 
the fine needle aspiration, followed by inguinal and pelvic lymphadenectomy if an 
adequate response to chemotherapy was documented.
In others of RAIL, descriptions the patients staging where up to cN2 and less 
than 3 cm in size lymph nodes, as equal for VEIL studies (Figure 4).
4.4 Patient preparation and position
An initial challenge presents itself at the beginning of the procedure: the position-
ing of the da Vinci robot and the operation table. Initially, the robot was placed on the 
right side of the table, considering it was an SI system that did not require reposition-
ing but simply redocking of the instruments. As a first step, the operating field is 
prepared and readied by having the patients lie in the dorsal decubitus position with 
abduction of both legs dressed since the beginning of the procedure to avoid time loss.
The preparation is then followed by realizing a medial incision localized in the 
femoral triangle, inside the Sartorius muscle and joint with the adductor longus.  
A 3 cm incision is realized 5 cm over the knee, under protection of the skin and 
small fatty tissue from the leg, we follow a digital dissection in direction of the 
inguinal ligament. This blunt finger dissection is accompanied with movements 
to the left and right sides of the thigh and heading also as upper as possible. The 
previous dissection is realized for the superficial plane of the lymph’s (Figure 5).
4.5 Surgical technique
4.5.1 Trocar placement: anterior, lateral, and posterior boundaries
Once we have created this space manually, three more incisions will be per-
formed. The first, a 5 mm one that will serve as a laparoscopic port, is placed 2 cm 
medial and below the initial incision of the left leg, while replicating this incision 
on the right leg (on its lateral side) and at the same distance, also 2 cm, so that the 
assistant port is external to the position of both legs. Right away, one of the robotic 
ports is placed 2 cm higher on the external side of the left leg, and one more robotic 
Figure 4. 
Surgical indications for inguinal lymphadenectomy in penile cancer.
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port is situated 3 cm to the left of the initial incision, on the same leg. This is where 
the camera port will be placed.
For the right leg, the first robotic port is placed 2 cm higher on the leg’s external side, 
and the second robotic port is located 3 cm to the right of the initial incision on this leg. 
This description is done simultaneously so that both legs are ready to dock the robot.
In the case of da Vinci X or Xi, right-side placement is also performed simply 
with a redocking of the arms, which allow for smaller incisions and for the camera 
to be changed to another robotic port, as well as the advantage of an easier, faster, 
and better position in the middle of the abducted legs of the patient. For every kind 
of model of the da Vinci systems, we use 0° lens, and once the ports are installed, 
the CO2 insufflation is managed at 10 mmHg (Figure 6).
Once the docking is done, under the da Vinci system’s 0° lens, the anatomical 
references of the femoral triangle and the packet of superficial nodes are located 
over the fascia lata. When performing a deep node dissection, we transected the 
fascia lata with each trocar staying laterally to the adductor longus and sartorius 
muscles doing a work below the fascia. The CO2 insufflation creates a working 
space, so we follow the middle of the muscles to find femoral nerve and vessels 
removing the femoral nodes (Figure 7).
After this, the trocars are slightly pulled up (without redocking) hence staying 
only on the superficial level. We lift up the superficial packet and follow the packet 
to the inguinal ligament, lateral to the saphenous vein, which is not always respect 
but transected, going higher to the saphenofemoral junction, an reaching the 
superficial nodes packet Figure 8.
Figure 5. 
Skin incision and finger dissection.
Figure 6. 
Trocars’ position and docking.
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The control of the saphenofemoral junction can be performed with either metal-
lic clips or 10 mm hem-o-lok; this junction is found over the muscles fascia in the 
interior side of the leg (Figure 9).
The packet is placed in an endobag and removed via the initial incision or the 
camera’s main port. A drain is placed in each leg through the 5-mm incision trocar. 
See Figure 10.
Figure 9. 
Muscles fascia.
Figure 8. 
Inguinal ligament and superficial nodes.
Figure 7. 
Deep inguinal space.
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5. Our experience
Between 2015 and 2018, we have performed 12 cases (24 limbs) of robotic 
inguinal lymph node dissection, where the patient’s median age was 58 years old. 
A 100% of the patients had been diagnosed with penile squamous cell carcinoma, 
confirmed by biopsy, and had previously experienced a partial or total penec-
tomy. The TNM for the patients was T2–3, cN1–2, M0, G1–3. Operative room 
mean time was 110 min (range 90–230 min). The mean blood loss was 59 ml 
(35–85). None of the surgeries were converted to an open approach. The total 
mean number of dissected lymph was 148 and mean lymph nodes per case were 
12, and from those, 1.8 were positive for SCC per limb (n = 22 positive lymph 
nodes). Hospitalization median stay was 2.5 days (range 2–4 days), and the dura-
tion of the drainage on overage 16 days (range 10–21 days). Complications were 
classified as Clavien-Dindo III (lymphocele: 2/24) whom needed single percuta-
neous drainage and 10 days of antibiotic treatment, however, did not require any 
hospital stay (Tables 1 and 2).
Figure 10. 
Nodes packet and drain.
No. of patients (limbs) 12 (24)
Age (range) 58 years old (41–73)
Histological type Penile SCC
Operative time (range) 110 min (90–230)
Blood loss (range) 59 ml (35–85)
Conversion to open surgery None
Total of dissected lymph nodes (mean per patient) 148 (12)
No. of total positive nodes (mean per patient) 22 (1.8)
Hospital stay (range) 2.5 days (2–4)
Duration of drainage (range) 16 days (10–21)
Postoperative complications (n) Lymphocele (2/12)
Table 1. 
Description group.
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Author Year Case 
report/
case 
series
Number of 
patients (# 
limbs)
Age 
(mean 
-years)
Penile 
cancer 
(histologic)
T 
stage
Pre-LND 
cN stage
Lymph 
nodes 
dissected 
(n) - mean
Operative 
time (min)
Blood  
loss (mL)
Complications
Josephson 
et al. [4]
2009 Case 
report
1 (2) 37 SCC♦ T3 cN2 10/9* 120/130* 100/50* None
Matin et al. [5] 2013 Case 
series
10 (20) 62 SCC♦ T1–3 cN0-cN1 Left: 9, 
Right: 9
180–240 100 
(mean)
Cellulitis (2/10), 
wound breakdown 
(2/10), skin 
necrosis (1/10)
Sotelo et al. [6] 2013 Case 
report
1 (2) 64 SCC♦ T3 cN0 33 360 100 Lymphocele
Corona-
Montes et al. 
[9]
2015 Case 
report
1 (2) 73 SCC♦ T3 cN0 NA 230 50 None
Ahlawat et al. 
[7]
2016 Case 
series
3 (6) 56 SCC♦ T2-T3 cN1-cN2 Left: 18, 
Right: 14
453 147 (mean) Lymphocele (1/3)
Our experience 2018 Case 
series
12 (24) 58 SCC♦ T2-T3 cN1-cN2 12 110 59 (mean) Lymphocele 
(2/12)
*RAIL performed in two separate procedures (one OR time per limb).
♦Squamous cell carcinoma of the penis.
Table 2. 
RAIL comparative reports.
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6. Conclusions
The robotic inguinal lymphadenectomy for penile cancer is still a novel 
technique that requires further studies to thoroughly demonstrate its utility. The 
open approach has shown an increased morbidity and rate of complications, 
primary producing flap skin necrosis, longer hospitalization stays, and infec-
tions. On the contrary, RAIL provides a three-dimensional vision and improved 
dexterity thanks to the articulated instruments that allow surgeons to work in a 
very reduced workspace, produce less surgical trauma to the skin, reduce opera-
tive time (while winning experience in anatomy field and in the docking of the 
robot), and perform both superficial and deep lymphadenectomy in both legs as 
previous approaches. The challenges for the aforementioned robotic approach 
are not only the high costs implied but also the learning curve for the femoral 
triangle anatomy and anatomical variations. There is not enough prospective 
evidence about robotic inguinal approach for penile cancer, but what can be 
affirmed is that the previously presented evidence report not only less mor-
bidity with minimally invasive techniques (VEIL, RAIL) and equal oncologic 
results.
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